EndoBarrier治疗长期2型糖尿病和肥胖症:90例连续治疗患者在EndoBarrier治疗后一年的结果

IF 0.5 Q4 ENDOCRINOLOGY & METABOLISM Practical Diabetes Pub Date : 2022-05-01 DOI:10.1002/pdi.2393

R. Ryder, M. Yadagiri, W. Burbridge, S. Irwin, H. Gandhi, T. Bashir, Rachael A Allden, Melanie C. Wyres, M. Cull, Jo Bleasdale, E. Fogden, Mark R. Anderson, Piya Sen Gupta

{"title":"EndoBarrier治疗长期2型糖尿病和肥胖症:90例连续治疗患者在EndoBarrier治疗后一年的结果","authors":"R. Ryder, M. Yadagiri, W. Burbridge, S. Irwin, H. Gandhi, T. Bashir, Rachael A Allden, Melanie C. Wyres, M. Cull, Jo Bleasdale, E. Fogden, Mark R. Anderson, Piya Sen Gupta","doi":"10.1002/pdi.2393","DOIUrl":null,"url":null,"abstract":"Aims: EndoBarrier is a 60cm duodenal–jejunal bypass liner endoscopically implanted for up to one year and designed to mimic the by‐pass part of Roux‐en‐Y bariatric surgery. We aimed to assess the safety and efficacy of EndoBarrier in patients with suboptimally‐controlled diabesity.","PeriodicalId":20309,"journal":{"name":"Practical Diabetes","volume":"2011 1","pages":""},"PeriodicalIF":0.5000,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"EndoBarrier treatment for longstanding type 2 diabetes and obesity: outcomes one year after EndoBarrier in 90 consecutively treated patients\",\"authors\":\"R. Ryder, M. Yadagiri, W. Burbridge, S. Irwin, H. Gandhi, T. Bashir, Rachael A Allden, Melanie C. Wyres, M. Cull, Jo Bleasdale, E. Fogden, Mark R. Anderson, Piya Sen Gupta\",\"doi\":\"10.1002/pdi.2393\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Aims: EndoBarrier is a 60cm duodenal–jejunal bypass liner endoscopically implanted for up to one year and designed to mimic the by‐pass part of Roux‐en‐Y bariatric surgery. We aimed to assess the safety and efficacy of EndoBarrier in patients with suboptimally‐controlled diabesity.\",\"PeriodicalId\":20309,\"journal\":{\"name\":\"Practical Diabetes\",\"volume\":\"2011 1\",\"pages\":\"\"},\"PeriodicalIF\":0.5000,\"publicationDate\":\"2022-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Practical Diabetes\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1002/pdi.2393\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Practical Diabetes","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/pdi.2393","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}

引用次数: 2

摘要

目的:EndoBarrier是一个60厘米的十二指肠-空肠旁路衬垫，在内镜下植入长达一年，旨在模拟Roux - en - Y减肥手术的旁路部分。我们的目的是评估EndoBarrier对控制欠佳的糖尿病患者的安全性和有效性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

EndoBarrier treatment for longstanding type 2 diabetes and obesity: outcomes one year after EndoBarrier in 90 consecutively treated patients

Aims: EndoBarrier is a 60cm duodenal–jejunal bypass liner endoscopically implanted for up to one year and designed to mimic the by‐pass part of Roux‐en‐Y bariatric surgery. We aimed to assess the safety and efficacy of EndoBarrier in patients with suboptimally‐controlled diabesity.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Practical Diabetes ENDOCRINOLOGY & METABOLISM-

CiteScore

1.10

自引率

16.70%

发文量

期刊介绍： Practical Diabetes concerns itself with all aspects of the worldwide clinical science and practice of diabetes medicine. The journal recognises the importance of each member of the healthcare team in the delivery of diabetes care, and reflects this diversity of professional interest in its editorial contents. The Editors welcome original papers, case reports, practice points, audit articles and letters on any aspect of clinical diabetes care from any part of the world. The journal also publishes commissioned leaders, review articles and educational and training series, for which an honorarium normally is paid. All articles submitted to Practical Diabetes are independently peer reviewed. They must not have been published or be under submission currently elsewhere. Enquiries from prospective authors are welcomed and the Editors will be pleased, if asked, to advise on preparation and submission of articles. All articles and enquiries should be directed to the Editors at the publishing address below. The journal is published nine times a year, and currently the average waiting time for acceptance of articles is eight weeks, and for subsequent publication sixteen weeks. Practical Diabetes is independent of any commercial or vested interest.